Switch View
© Globe Newswire
30.10.2025
ISIN: US03753U1060
Apellis Pharmaceuticals Inc
APLS
LISTED
NASDAQ
Apellis Pharmaceuticals Reports Third Quarter 2025 Financial Results
News Preview
WALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), today announced its third quarter 2025 financial results and business highlights....
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US1255091092
Cigna Group (The)
CI
LISTED
NYSE
The Cigna Group Reports Strong Third Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook
News Preview
Total revenues for the third quarter 2025 increased 10% to $69.7 billion
Shareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per share
Adjusted income...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US68404L2016
Option Care Health Inc
OPCH
LISTED
NASDAQ
Option Care Health Announces Financial Results For the Third Quarter Ended September 30, 2025
News Preview
BANNOCKBURN, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
30.10.2025
ISIN: US71722W1071
Phathom Pharmaceuticals Inc
PHAT
LISTED
NASDAQ
Phathom Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
FLORHAM PARK, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the third quarter ended September 30, 2025, and provided a business update....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
30.10.2025
ISIN: US88688T1007
Tilray Brands Inc
TLRY
LISTED
TSX
Tilray Brands Sets Sights on Asia: Bringing Award-Winning Craft Beers to Japan’s Premier American Craft Beer Experience Festival
News Preview
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, is bringing its celebrated craft beer brands to the heart of Asia. Tilray will debut select craft brands at the highly anticipated...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US00847X1046
Agios Pharmaceuticals Inc
AGIO
LISTED
NASDAQ
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update
News Preview
Agios today announced financial results and updates for the third quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US09075X1081
Biodesix Inc
BDSX
LISTED
NASDAQ
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting
News Preview
Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fish...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US03168L1052
Amneal Pharmaceuticals Inc
AMRX
LISTED
NASDAQ
Amneal Reports Third Quarter 2025 Financial Results
News Preview
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US4579852082
Integra Lifesciences Holdings Corp
IART
LISTED
NASDAQ
Integra LifeSciences Reports Third Quarter 2025 Financial Results
News Preview
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: DK0062498333
Novo Nordisk A/S
NOVO B
LISTED
CPH
Novo Nordisk submits proposal to acquire Metsera, Inc.
News Preview
Bagsværd, Denmark, 30 October 2025 – Novo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera, Inc. (Metsera)....
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.10.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds
News Preview
NEW YORK, NY / ACCESS Newswire / October 30, 2025 / In the face of growing global concern over the potential use of chemical weapons such as the nerve agent Sarin, Lunai Bioworks Inc. (NASDAQ:LNAI) today announced promising early results from its AI-based platform designed to identify compounds that interact with acetylcholinesterase (AChE), the sa...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US45784P1012
Insulet Corp
PODD
LISTED
NASDAQ
Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month
News Preview
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its new campaign, “The Day Diabetes Showed Up to Work,” in honor of Diabetes Awareness Month, which starts November 1.
“Nearly 590 million people worldwide live with diabetes1, an...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
30.10.2025
ISIN: KR7068270008
Celltrion Inc
68270
LISTED
KSC
U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
News Preview
The U.S. FDA approved STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) as interchangeable with the reference products PROLIA® (denosumab) and XGEVA® (denosumab), respectively, for all approved indications, effective as of October 29, 2025
The interchangeability (IC) designations of STOB...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
ISIN: JP3463000004
Takeda Pharmaceutical Co Ltd
45020
LISTED
XJPX
Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
News Preview
News Release
Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
OSAKA, Japan, October 30, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced the revised forecast of the full year consolidated financials for the fiscal year ending March 31, 2026 (FY2025), as below.
Takeda’s fiscal year 2025 first half results a......
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
News Preview
Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation.
First clinical data supports imlifidase ability to substantially reduce anti-AAV antibodies to allow administration of gene t...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: SE0002148817
Hansa Biopharma AB
HNSA
LISTED
STO
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results
News Preview
Imlifidase successfully met primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation.
First clinical data supports imlifidase ability to substantially reduce anti-AAV antibodies to allow administration of gene t...
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
ISIN: CH1243598427
Sandoz Group AG
SDZ
LISTED
XWSX
Sandoz delivers a further acceleration in sales growth; full-year margin guidance upgraded
News Preview
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules
Basel, October 30, 2025 - Sandoz (SIX: SDZ / OTCQX: SDZNY), the global leader in affordable medicines, today presents its net-sales performance for the nine months and third quarter ended September 30, 2025.
9M net sales of USD 8,057 million
up by 5% at constant currencies (C......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
News Preview
Press Release // October 30, 2025
Formycon invites to Conference Call on 2025 Nine-Month Results and announces Participation in Investor Conferences in the 4th Quarter of 2025
Planegg-Martinsried, Germany – Formycon AG (FSB: FYB, Prime Standard, „Formycon“) plans to publish its Nine-Month Results 2025 on November 13, 2025. The Management Boar......
Themefolio
Profiler
Peergroup
© EQS Newswire
30.10.2025
ISIN: DE000A1EWVY8
Formycon AG
FYB
LISTED
XETR
Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2025 ein und gibt Teilnahme an Investorenkonferenzen im 4. Quartal 2025 bekannt
News Preview
Pressemitteilung // 30. Oktober 2025
Formycon lädt zur Telefonkonferenz zum Neunmonatsergebnis 2025 ein und gibt Teilnahme an Investorenkonferenzen im 4. Quartal 2025 bekannt
Planegg-Martinsried – Die Formycon AG (FWB: FYB, Prime Standard, „Formycon“) plant die Neunmonatszahlen 2025 am 13. November 2025 zu veröffentlichen. Der Vorstand wird di......
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
QUVIVIQ sales up >130% driving Idorsia toward profitability – 9M 2025 results
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: CH0012032048
Roche Holding AG
ROG
LISTED
SIX
Roche purchases shares in tender offer for 89bio, Inc
News Preview
Basel, 30 October 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Bluefin Merger Subsidiary, Inc., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common stock of 89bio, Inc. (“89bio”, NASDAQ: ETNB) at a price of...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: KYG3224E1061
Everest Medicines Limited
1952
LISTED
HKSE
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
News Preview
Everest Medicines acquired an exclusive license to develop, manufacture, and commercialize VIS-101 in Greater China, Singapore, South Korea, and certain Southeast Asian countries.
Under the assigned exclusive license, Everest Medicines will make an upfront payment of US$7 million (equivalent to...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: KYG4783B1032
Innocare Pharma Limited
9969
LISTED
HKSE
Latest Data of InnoCare's Zurletrectinib Orally Presented at SIOP 2025
News Preview
Zurletrectinib demonstrated well-tolerated safety and promising antitumor activity in pediatric/adolescent patients with NTRK/ROS1-altered solid tumors....
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the pricing of an underwritten public offering of 18,375,000 common shares, without par value, at a public offering price of $12.25 per common...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: SG9999014716
WAVE Life Sciences Ltd
WVE
LISTED
NASDAQ
Correcting and Replacing Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day
News Preview
This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical error in the first sub-bullet under “WVE-007 (GalNAc-siRNA)” – “Next steps.”...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants
News Preview
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten public offering of 23,809,524 shares of its common stock at a price of $4.20 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 7,142,85...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Reports Third Quarter 2025 Results
News Preview
BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended September 26, 2025.
This was...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Oct. 29, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek appointment as lead plaintif...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: KYG0519B1023
Ascentage Pharma Group International
6855
LISTED
HKSE
Ascentage Pharma to Participate in Two Upcoming Investor Conferences in November 2025
News Preview
ROCKVILLE, Md. and SUZHOU, China, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO)
News Preview
PHILADELPHIA, Oct. 29, 2025 /PRNewswire/ -- Berger Montague PC advises shareholders of Akero Therapeutics, Inc. ("Akero" or the "Company") about an investigation into the Company and members of its Board of Directors for potential breaches of fiduciary duties and violations of the federal securities laws....
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
News Preview
Châtillon, France, October 29, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: DE0005550602
Draegerwerk AG & Co KGaA
DRW8
LISTED
XETR
Dräger achieves perfect-score CMMC Level 2 Certification reinforcing cybersecurity leadership in Defense and Government healthcare and safety technology
News Preview
Certification ensures the highest level of data security for mission-critical medical and safety technology
TELFORD, Pa., Oct. 29, 2025 /PRNewswire/ -- Draeger, Inc., part of the Dräger group of corporations ('Dräger') and a leading provider of medical and safety technology, has achieved Cybersecu...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries
News Preview
ROCKVILLE, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced that its subsidiary Visara, Inc. (Visara) has assigned it exclusive license agreement to Everest Medicines (HKEX: 1952...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US00287Y1091
AbbVie Inc
ABBV
LISTED
EURONEXT
The One & Only BOTOX® Cosmetic (onabotulinumtoxinA) Day Returns November 19 with the Biggest Celebration of the Year
News Preview
Allergan Aesthetics gives patients exciting BOTOX® Cosmetic offers only in the Allē app
Buy one $50 gift card, get one free, plus, register, book a consultation, and get treated for a chance to win $25,000*†
IRVINE, Calif., Oct. 29, 2025 /PRNew...
Themefolio
Profiler
Peergroup
© Globe Newswire
29.10.2025
ISIN: US4277461020
Heron Therapeutics Inc
HRTX
LISTED
NASDAQ
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
News Preview
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board of Directors. Mr. Cusack has extensive experience in matters related to corporate finance, investment management, and corporate go...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH)....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Inc. (SVRA) Shareholders Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Savara Inc. ("Savara" or the "Company") (NASDAQ: SVRA)....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Deadline Alert: Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP reminds investors of the upcoming December 2, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Molina Healthcare, Inc. ("Molina" or the "Company") (NYSE: MOH...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against aTyr Pharma Inc. ("aTyr" or the "Company") (NASDAQ: ATYR)....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
Cytokinetics, Incorporated (CYTK) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
News Preview
LOS ANGELES, Oct. 29, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Cytokinetics, Incorporated ("Cytokinetics" or the "Company") (NASDAQ: CYTK) have opportunity to lead the securities fraud class action lawsuit....
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
Deadline Approaching: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged to Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
IF YOU ARE...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
Deadline Approaching: MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 15, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025, inclusive (the “Class Period”).
IF...
Themefolio
Profiler
Peergroup
© Newsfile
29.10.2025
ISIN: CA25380E1060
Digicann Ventures Inc.
DCNN
LISTED
CSE
Digicann Ventures Agrees to Mutual Termination of Business Combination Agreement with 3Win Corp. and D-3 Merger Sub, Inc.
News Preview
Vancouver, British Columbia--(Newsfile Corp. - October 29, 2025) - Digicann Ventures Ltd. (CSE: DCNN) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis industry, announces that on October 22, 2025 it entered into a Termination, Settlement and Release Agreement (the "Settlement Agreement")...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Encompass Health reports results for third quarter 2025
News Preview
Increases full-year guidance
BIRMINGHAM, Ala., Oct. 29, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the thi...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK Investors Have Opportunity to Lead Cytokinetics, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 29, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Cytokinetics, Inc. (NASDAQ...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9139031002
Universal Health Services Inc
UHS
LISTED
NYSE
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT THE 2025 WOLFE RESEARCH HEALTHCARE CONFERENCE
News Preview
KING OF PRUSSIA, Pa., Oct. 29, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the Wolfe Research Healthcare Conference 2025 in New York, New York on Wednesday, November 19, 2025, at 8:00 a.m. EST.
A live audio webcast of the presentation and a webcast r...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US29415F1049
Envista Holdings Corp
NVST
LISTED
NYSE
Envista Announces Release of 2024 Sustainability Report
News Preview
BREA, Calif., Oct. 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2024 Sustainability Report, highlighting ongoing efforts to pursue progress with purpose as it integrates sustainable and responsible business practices to achieve its mission of partnering wit...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8688731004
Surmodics Inc
SRDX
LISTED
NASDAQ
Surmodics Announces Results from Sex-Specific Analysis of the PROWL Registry Study of Real-World Limb Ischemia Patients Treated with the Pounce™ Thrombectomy Platform
News Preview
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic thrombotic limb ischemia patients from its PROWL registry study were presented by Dr. Peter Monteleone at the...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US0905722072
Bio Rad Laboratories, Inc.
BIO
LISTED
NYSE
Bio-Rad Reports Third-Quarter 2025 Financial Results
News Preview
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2025.
“During the third quarter, we continued to navigate a dynamic global environment and evolving conditions across the markets for our life sc...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US2289031005
Artivion Inc
AORT
LISTED
NYSE
Artivion to Participate in the Stifel 2025 Healthcare Conference
News Preview
ATLANTA, Oct. 29, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate at the upcoming Stifel 2025 Healthcare Conference on Wednesday, November 12, 2025, at the Lotte New York Palace Hotel. The Company'...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US8051111016
Savara Inc
SVRA
LISTED
NASDAQ
Savara Announces Proposed Public Offering
News Preview
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. The proposed of...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US23918K1088
DaVita Inc
DVA
LISTED
NYSE
DaVita Inc. 3rd Quarter 2025 Results
News Preview
DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025.
"Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance," said Javier Rodriguez, CEO of...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US89377M1099
Transmedics Group Inc
TMDX
LISTED
NASDAQ
TransMedics Reports Third Quarter 2025 Financial Results
News Preview
ANDOVER, Mass., Oct. 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended September 30, 2025....
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US9467841055
Waystar Holding Corp.
WAY
LISTED
NASDAQ
Waystar Reports Third Quarter 2025 Results
News Preview
Q3 revenue growth of 12% year-over-year
Q3 net income of $30.6 million and non-GAAP net income of $67.8 million
Q3 net income margin of 11%; adjusted EBITDA margin of 42%...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2025
ISIN: US92686J1060
Viking Therapeutics Inc
VKTX
LISTED
NASDAQ
Viking Therapeutics to Highlight Clinical Data from VK2735 Obesity Program in Presentations at ObesityWeek® 2025
News Preview
Poster Presentation on VENTURE Study Results Evaluating Impact of VK2735 on Prediabetes and Cardiometabolic Status
Additional Poster Presentations Scheduled for American Heart Association Scientific S...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US2854091087
Electromed, Inc.
ELMD
LISTED
XASE
Electromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025
News Preview
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first quarter ended September 30, 2025, on Wednesday, November 12, 2025 after the close of the stock market. Company management will...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US3773221029
Glaukos Corp
GKOS
LISTED
NYSE
Glaukos Announces Third Quarter 2025 Financial Results
News Preview
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial results for the third quarter ended September 30, 2025. Key highlights include:
Record net sales of $133.5 million in Q3 2025 i...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US69120X2062
Owlet Inc
OWLT
LISTED
NYSE
Owlet to Report Third Quarter 2025 Financial Results on November 13, 2025
News Preview
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), the pioneer of smart infant monitoring, plans to announce third quarter 2025 financial results after market close on Thursday, November 13, 2025. Owlet’s President and Chief Executive Officer, Jonathan Harris, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 4:3...
Themefolio
Profiler
Peergroup
© BusinessWire
29.10.2025
ISIN: US40131M1099
Guardant Health Inc
GH
LISTED
NASDAQ
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
News Preview
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
For the three-month period ended September 30, 2025, as compared to the same period of 2024:
Reported total revenue of $265.2 million, an increase of 39%...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
